GlycoDiaRisk
The first glycan-based diagnostics for efficient early detection and prevention of type 2 diabetes
GlycoDiaRisk transfers GlycanAge’s plasma N-glycan analysis from UPLC to high-throughput capillary gel electrophoresis (CGE-LIF), making glycan profiling faster and more affordable for routine use. Building on this method, the project adapts a glycan-based risk model for very early prediction of type 2 diabetes, while the disease can still be prevented. The integrated workflow will be tested in a clinical laboratory setting.
- Duration
- 1 September 2026 – 31 August 2028
- Total project value
- EUR 712,650.33
- Grant amount
- EUR 498,855.23
- Beneficiary
- GlycanAge d.o.o.
This project is financed under the Digital, Innovation and Green Technology Project (DIGIT Project), implemented by the Ministry of Science, Education and Youth and the Croatian Science Foundation and financed by a loan of the International Bank for Reconstruction and Development (World Bank), Loan No. 9558-HR, grant agreement DIGIT.2.2.01.022. The project proposal was awarded the Seal of Excellence under Horizon Europe (EIC Pre-Accelerator).

Comments, suggestions and complaints
Comments, suggestions or complaints related to the GlycoDiaRisk project can be sent to glycodiarisk@glycanage.com. All submissions are recorded and answered. You can also contact the DIGIT Project grievance mechanism at grmdigit@hrzz.hr.